T
Thierry Urban
Researcher at University of Angers
Publications - 89
Citations - 3685
Thierry Urban is an academic researcher from University of Angers. The author has contributed to research in topics: Lung cancer & Population. The author has an hindex of 26, co-authored 83 publications receiving 2983 citations. Previous affiliations of Thierry Urban include French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives
Julien Mazieres,Solange Peters,Benoit Lepage,Alexis B. Cortot,Fabrice Barlesi,Michèle Beau-Faller,Benjamin Besse,Hélène Blons,Audrey Mansuet-Lupo,Thierry Urban,Denis Moro-Sibilot,Eric Dansin,Christos Chouaid,Marie Wislez,Joachim Diebold,Enriqueta Felip,Isabelle Rouquette,Julie Milia,Oliver Gautschi +18 more
TL;DR: This study, the largest to date dedicated to Her2-mutated NSCLC, reinforces the importance of screening for HER2 mutations in lung adenocarcinomas and suggests the potential efficacy of HER2-targeted drugs in this population.
Journal ArticleDOI
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients.
Fabrice Denis,Claire Lethrosne,N. Pourel,Olivier Molinier,Yoann Pointreau,Julien Domont,Hugues Bourgeois,Hélène Senellart,P. Trémolières,T. Lizée,Jaafar Bennouna,Thierry Urban,Claude El Khouri,Alexandre Charron,Anne-Lise Septans,Magali Balavoine,Sébastien Landry,Philippe Solal-Celigny,Christophe Letellier +18 more
TL;DR: A web-mediated follow-up algorithm based on self-reported symptoms improved OS due to early relapse detection and better performance status at relapse.
Journal ArticleDOI
Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer.
Fabrice Denis,Ethan Basch,Anne Lise Septans,Jaafar Bennouna,Thierry Urban,Amylou C. Dueck,Christophe Letellier +6 more
TL;DR: In this article, the authors report 2-year survival outcomes among patients with advanced nonprogressive stage IIA to IV lung cancer randomized to symptom monitoring during chemotherapy via web-based patient-reported outcomes vs standard scheduled imaging after treatment to detect symptomatic recurrence.
Journal ArticleDOI
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial
Arnaud Scherpereel,Julien Mazieres,Laurent Greillier,Sylvie Lantuejoul,Pascal Do,O. Bylicki,Isabelle Monnet,Romain Corre,Clarisse Audigier-Valette,M. Locatelli-Sanchez,Olivier Molinier,Florian Guisier,Thierry Urban,Catherine Ligeza-poisson,David Planchard,E. Amour,Franck Morin,Denis Moro-Sibilot,Gérard Zalcman,Didier Debieuvre,Sandrine Hiret,Jacques Cadranel,Séverine Fraboulet-Moreau,Delphine Carmier +23 more
TL;DR: This multicentre randomised, non-comparative, open-label, phase 2 trial aimed to prospectively assess the anti-PD-1 monoclonal antibody alone or in combination with anti-cytotoxic T-lymphocyte protein 4 (CTLA-4) antibody in patients with malignant pleural mesothelioma.
Journal ArticleDOI
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome
N. Meslier,Frédéric Gagnadoux,P. Giraud,C. Person,H Ouksel,Thierry Urban,Jean-Louis Racineux +6 more
TL;DR: The authors conclude that in a clinic-based sample of patients, obstructive sleep apnoea syndrome is associated with a high frequency of type‐2 diabetes and impaired glucose tolerance and the relationship between sleep-disordered breathing and glucose-insulin metabolism is independent of obesity and age.